CL monthly performance report
Explore CL's monthly returns, drawdown, and seasonality trends — updated every month.
CL monthly report
—
Key takeaways
- Colgate-Palmolive (CL) closed November 2026 at $99.67, up 4.60% for the month and +26.50% over the trailing 12 months.
- Year-to-date, CL is +26.13%, outperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +10.39% versus its 200-day moving average ($90.29), a bullish technical signal.
- Over the past three years, CL has underperformed the S&P 500 by −40.14%, with a relative strength index reading of 76.6.
- Win rate over the trailing 39 months stands at 61.5% — 24 positive months versus 15 negative months.
Colgate-Palmolive ended November 2026 at $99.67, posting a monthly return of +4.60%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +4.78%.
The current quarter stands at +16.82% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +10.39% versus the 200-day moving average ($90.29).
Year-to-date, CL is +26.13% against SPY +10.62%, a gap of +15.51%. The stock is currently −1.48% below its 52-week high, with maximum 3-year drawdown at −31.07%.
| Period | CL | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +1.81% | −0.36% | +2.17% |
| 1 Week | +3.22% | +2.59% | +0.63% |
| 1 Month | +4.60% | −0.18% | +4.78% |
| 3 Months | +10.49% | −2.37% | +12.86% |
| 6 Months | +12.19% | +0.83% | +11.36% |
| YTD | +26.13% | +10.62% | +15.51% |
| 12 Months | +26.50% | +12.25% | +14.25% |
| 3 Years | +31.23% | +71.37% | −40.14% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jan 2026 | +14.26% |
| #2 | Oct 2026 | +11.69% |
| #3 | Feb 2026 | +9.80% |
| #4 | Aug 2024 | +7.37% |
| #5 | Oct 2023 | +5.64% |
| Rank | Month | Return |
|---|---|---|
| #1 | Mar 2026 | −14.03% |
| #2 | Oct 2024 | −9.73% |
| #3 | Jul 2025 | −7.76% |
| #4 | Dec 2024 | −5.92% |
| #5 | Sep 2026 | −5.01% |
| Quarter | Return |
|---|---|
| Q3 2025 | −12.06% |
| Q4 2025 | −1.15% |
| Q1 2026 | +7.86% |
| Q2 2026 | +7.57% |
| Q3 2026 | −6.94% |
| Q4 2026 (QTD) | +16.82% |
| Year | Return |
|---|---|
| 2023 | +1.17% |
| 2024 | +14.05% |
| 2025 | −13.08% |
| 2026 | +26.13% |
| Metric | Value |
|---|---|
| 52-Week High | $101.17 (2026-11-05) |
| 52-Week Low | $75.96 (2026-01-05) |
| Current Price | $99.67 |
| 200-Day Moving Average | $90.29 |
| Price vs 200DMA | +10.39% |
| 3-Year Maximum Drawdown | −31.07% (2025-11-03) |
| Current Drawdown from 52W High | −1.48% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 76.6 |
| 3-Year Excess Return vs S&P 500 | −40.14% |
| RS Peak | 115.7 (Sep 2024) |
| RS Trough | 63.5 (Oct 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CL's return for this report period?
CL returned +4.60% in the latest monthly window ending 2026-11-13.
Has CL outperformed SPY year to date?
YTD CL: +26.13% vs SPY: +10.62%.
What is CL's 12-month return?
+26.50% over the trailing 12 months.
Is CL above or below its 200-day moving average?
Price is +10.39% versus 200DMA ($90.29).
What is the maximum drawdown in the 3-year window?
−31.07% on 2025-11-03.